Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
Date | Price Target | Rating | Analyst |
---|---|---|---|
10/7/2025 | $37.00 | Buy | Goldman |
10/7/2025 | $36.00 | Outperform | BMO Capital Markets |
10/7/2025 | $38.00 | Outperform | Bernstein |
10/7/2025 | $34.00 | Hold | Jefferies |
10/7/2025 | $35.50 | Buy | Rothschild & Co Redburn |
10/7/2025 | $36.00 | Outperform | RBC Capital Mkts |
10/7/2025 | $36.00 | Buy | Stifel |
10/7/2025 | $40.00 | Buy | BTIG Research |
Goldman initiated coverage of Legence Corp. with a rating of Buy and set a new price target of $37.00
BMO Capital Markets initiated coverage of Legence Corp. with a rating of Outperform and set a new price target of $36.00
Bernstein initiated coverage of Legence Corp. with a rating of Outperform and set a new price target of $38.00
4 - Legence Corp. (0002052568) (Issuer)
SCHEDULE 13G - Legence Corp. (0002052568) (Subject)
S-8 - Legence Corp. (0002052568) (Filer)
8-K - Legence Corp. (0002052568) (Filer)
SAN JOSE, Calif., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Legence Corp. ("Legence") announced today the closing of its initial public offering (the "offering") of 26,000,000 shares of its Class A common stock (the "Common Stock") at a price to the public of $28.00 per share. In addition, the underwriters partially exercised their option and purchased 3,487,627 additional shares of Common Stock. The Common Stock began trading on the Nasdaq Global Select Market ("Nasdaq") on September 12, 2025 under the ticker symbol "LGN." Legence received net proceeds of approximately $780.2 million, after deducting underwriting discounts and commissions. Legence intends to use such net proceeds for the repaym
4 - Legence Corp. (0002052568) (Issuer)
4 - Legence Corp. (0002052568) (Issuer)
4 - Legence Corp. (0002052568) (Issuer)